| 1 | Robinow syndrome, autosomal dominant 1 | Enrichment | DVL1, FZD2, WNT5A | 5.35 |
| 2 | Autosomal dominant robinow syndrome | Enrichment | DVL1, FZD2, WNT5A | 5.35 |
| 3 | Robinow syndrome, autosomal recessive 1 | Enrichment | DVL1, FZD2, WNT5A | 4.96 |
| 4 | Autosomal recessive robinow syndrome | Enrichment | DVL1, FZD2, WNT5A | 4.66 |
| 5 | Early-onset autosomal dominant alzheimer disease | Enrichment | APP, PSEN1, PSEN2 | 4.42 |
| 6 | Hepatocellular carcinoma | Enrichment | APC, AXIN1, CASP8, CTNNB1 | 4.14 |
| 7 | Adult hepatocellular carcinoma | Enrichment | AXIN1, CASP8, CTNNB1 | 4.05 |
| 8 | Proteasome-associated autoinflammatory syndrome 3 | Enrichment | PSMB4, PSMB9 | 3.96 |
| 9 | Desmoid disease, hereditary | Enrichment | APC, CTNNB1 | 3.49 |
| 10 | Proteasome-associated autoinflammatory syndrome 1 | Enrichment | PSMB4, PSMB8 | 3.49 |
| 11 | Osteoporosis, juvenile | Enrichment | WNT1, WNT3A | 3.49 |
| 12 | Alzheimer disease 4 | Enrichment | PSEN1, PSEN2 | 3.49 |
| 13 | Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | Enrichment | CACNA1A, CACNA1C | 3.49 |
| 14 | Desmoid tumor | Enrichment | APC, CTNNB1 | 3.49 |
| 15 | Proteosome-associated autoinflammatory syndrome | Enrichment | PSMB4, PSMB8 | 3.49 |
| 16 | Keratoacanthoma | Enrichment | NOTCH1, NOTCH2 | 3.49 |
| 17 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | CDH1, CTNNA1 | 3.19 |
| 18 | Ventricular fibrillation, paroxysmal familial, 1 | Enrichment | CACNA1C, RYR2 | 3.19 |
| 19 | Craniopharyngioma | Enrichment | APC, CTNNB1 | 3.19 |
| 20 | Malignant hyperthermia | Enrichment | CACNA1S, RYR1 | 3.19 |
| 21 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1, FZD4 | 2.97 |
| 22 | Robinow syndrome, autosomal dominant 2 | Enrichment | DVL1, FZD2 | 2.97 |
| 23 | Heart conduction disease | Enrichment | CACNA1C, RYR2 | 2.97 |
| 24 | Colorectal cancer | Enrichment | APC, CDH1, CTNNA1, CTNNB1, FZD3 | 2.66 |
| 25 | Adams-oliver syndrome | Enrichment | NOTCH1, RBPJ | 2.66 |
| 26 | Brugada syndrome | Enrichment | CACNA1C, CACNA2D1, CACNB2 | 2.61 |
| 27 | Auditory neuropathy | Enrichment | CACNA1A, CDH2, NOTCH3 | 2.61 |
| 28 | Exudative vitreoretinopathy | Enrichment | CTNNB1, FZD4 | 2.53 |
| 29 | Isolated split hand-split foot malformation | Enrichment | BTRC, WNT10B | 2.53 |
| 30 | Hydrops fetalis | Enrichment | RYR1, RYR3 | 2.43 |
| 31 | Long qt syndrome | Enrichment | CACNA1C, CACNA1S, RYR2 | 2.39 |
| 32 | Migraine with or without aura 1 | Enrichment | CACNA1A, NOTCH3 | 2.25 |
| 33 | Cardiac conduction defect | Enrichment | CACNA1C, RYR2 | 2.17 |
| 34 | Alzheimer's disease | Enrichment | APP, PSEN1 | 2.10 |
| 35 | Breast cancer | Enrichment | APC, CACNA2D1, CASP8, CDH1 | 2.10 |
| 36 | Medulloblastoma | Enrichment | APC, CTNNB1 | 2.04 |
| 37 | Cone-rod dystrophy 6 | Enrichment | CACNA1F, CACNA2D4 | 2.04 |
| 38 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | CDH2, RYR2 | 2.04 |
| 39 | Gastric cancer | Enrichment | APC, CASP10, CDH1 | 1.99 |
| 40 | Nail disorder, nonsyndromic congenital, 1 | Enrichment | FZD6 | 1.98 |
| 41 | Mullerian aplasia and hyperandrogenism | Enrichment | WNT4 | 1.98 |
| 42 | Ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome | Enrichment | CDH3 | 1.98 |
| 43 | Elsahy-waters syndrome | Enrichment | CDH11 | 1.98 |
| 44 | Thyrotoxic periodic paralysis 1 | Enrichment | CACNA1S | 1.98 |
| 45 | Caspase 8 deficiency | Enrichment | CASP8 | 1.98 |
| 46 | Epilepsy, idiopathic generalized 9 | Enrichment | CACNB4 | 1.98 |
| 47 | Macular dystrophy, patterned, 2 | Enrichment | CTNNA1 | 1.98 |
| 48 | 46,xx sex reversal with dysgenesis of kidneys, adrenals, and lungs | Enrichment | WNT4 | 1.98 |
| 49 | Brugada syndrome 4 | Enrichment | CACNB2 | 1.98 |
| 50 | Intellectual developmental disorder, autosomal dominant 3 | Enrichment | CDH15 | 1.98 |
| 51 | Omodysplasia 2 | Enrichment | FZD2 | 1.98 |
| 52 | Hajdu-cheney syndrome | Enrichment | NOTCH2 | 1.98 |
| 53 | Alagille syndrome 2 | Enrichment | NOTCH2 | 1.98 |
| 54 | Acne inversa, familial, 1 | Enrichment | NCSTN | 1.98 |
| 55 | Lateral meningocele syndrome | Enrichment | NOTCH3 | 1.98 |
| 56 | Split-hand/foot malformation 6 | Enrichment | WNT10B | 1.98 |
| 57 | Caudal duplication anomaly | Enrichment | AXIN1 | 1.98 |
| 58 | Tooth agenesis, selective, 8 | Enrichment | WNT10B | 1.98 |
| 59 | Episodic ataxia, type 5 | Enrichment | CACNB4 | 1.98 |
| 60 | Teebi hypertelorism syndrome 2 | Enrichment | CDH11 | 1.98 |
| 61 | Neurodevelopmental disorder with microcephaly, hypotonia, and absent language | Enrichment | PSMB1 | 1.98 |
| 62 | Congenital myopathy 20 | Enrichment | RYR3 | 1.98 |
| 63 | Neurodevelopmental disorder with speech impairment and with or without seizures | Enrichment | CACNA1I | 1.98 |
| 64 | Congenital myopathy 18 | Enrichment | CACNA1S | 1.98 |
| 65 | Diarrhea 9 | Enrichment | WNT2B | 1.98 |
| 66 | Cone-rod dystrophy, x-linked, 3 | Enrichment | CACNA1F | 1.98 |
| 67 | Retinal cone dystrophy 4 | Enrichment | CACNA2D4 | 1.98 |
| 68 | Agenesis of corpus callosum, cardiac, ocular, and genital syndrome | Enrichment | CDH2 | 1.98 |
| 69 | Cardiomyopathy, dilated, 1v | Enrichment | PSEN2 | 1.98 |
| 70 | Bone mineral density quantitative trait locus 16 | Enrichment | WNT1 | 1.98 |
| 71 | Primary aldosteronism, seizures, and neurologic abnormalities | Enrichment | CACNA1D | 1.98 |
| 72 | Deafness, cataract, impaired intellectual development, and polyneuropathy | Enrichment | PSMC3 | 1.98 |
| 73 | Hypotrichosis | Enrichment | CDH3 | 1.98 |
| 74 | Brugada syndrome 3 | Enrichment | CACNA1C | 1.98 |
| 75 | Epilepsy, childhood absence 6 | Enrichment | CACNA1H | 1.98 |
| 76 | Malignant hyperthermia 5 | Enrichment | CACNA1S | 1.98 |
| 77 | Autoimmune lymphoproliferative syndrome, type iia | Enrichment | CASP10 | 1.98 |
| 78 | Cerebral amyloid angiopathy, app-related | Enrichment | APP | 1.98 |
| 79 | Santos syndrome | Enrichment | WNT7A | 1.98 |
| 80 | Arrhythmogenic right ventricular dysplasia, familial, 14 | Enrichment | CDH2 | 1.98 |
| 81 | Cardiomyopathy, dilated, 1u | Enrichment | PSEN1 | 1.98 |
| 82 | Intellectual developmental disorder, autosomal dominant 10 | Enrichment | CACNG2 | 1.98 |
| 83 | Sinoatrial node dysfunction and deafness | Enrichment | CACNA1D | 1.98 |
| 84 | Proteasome-associated autoinflammatory syndrome 6 | Enrichment | PSMB9 | 1.98 |
| 85 | Myofibromatosis, infantile, 2 | Enrichment | NOTCH3 | 1.98 |
| 86 | Microphthalmia/coloboma 11 | Enrichment | FZD5 | 1.98 |
| 87 | Acne inversa, familial, 2, with or without dowling-degos disease | Enrichment | PSENEN | 1.98 |
| 88 | Spinocerebellar ataxia 42 | Enrichment | CACNA1G | 1.98 |
| 89 | Developmental and epileptic encephalopathy 110 | Enrichment | CACNA2D1 | 1.98 |
| 90 | Acne inversa, familial, 3 | Enrichment | PSEN1 | 1.98 |
| 91 | Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits | Enrichment | CACNA1G | 1.98 |
| 92 | Developmental and epileptic encephalopathy 69 | Enrichment | CACNA1E | 1.98 |
| 93 | Hyperaldosteronism, familial, type iv | Enrichment | CACNA1H | 1.98 |
| 94 | Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia | Enrichment | DOCK3 | 1.98 |
| 95 | Craniometadiaphyseal osteosclerosis with hip dysplasia | Enrichment | AXIN1 | 1.98 |
| 96 | Congenital myopathy with myasthenic-like onset | Enrichment | RYR1 | 1.98 |
| 97 | Attention deficit-hyperactivity disorder 8 | Enrichment | CDH2 | 1.98 |
| 98 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.98 |
| 99 | Intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly | Enrichment | CASP2 | 1.98 |
| 100 | Transient cerebral ischemia | Enrichment | NOTCH3 | 1.98 |
| 101 | Breast lobular carcinoma | Enrichment | CDH1 | 1.98 |
| 102 | Conn's syndrome | Enrichment | CACNA1H | 1.98 |
| 103 | Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 | Enrichment | NOTCH3 | 1.98 |
| 104 | Familial adenomatous polyposis | Enrichment | APC | 1.98 |
| 105 | Sporadic hemiplegic migraine | Enrichment | CACNA1A | 1.98 |
| 106 | Atypical timothy syndrome | Enrichment | CACNA1C | 1.98 |
| 107 | Aldosterone-producing adenoma with seizures and neurological abnormalities | Enrichment | CACNA1D | 1.98 |
| 108 | Timothy syndrome type 2 | Enrichment | CACNA1C | 1.98 |
| 109 | Gardner syndrome | Enrichment | APC | 1.98 |
| 110 | 5q22 microdeletion syndrome | Enrichment | APC | 1.98 |
| 111 | Pash syndrome | Enrichment | NCSTN | 1.98 |
| 112 | Periodic paralysis with transient compartment-like syndrome | Enrichment | CACNA1S | 1.98 |
| 113 | Attenuated familial adenomatous polyposis | Enrichment | APC | 1.98 |
| 114 | Huntington's disease-like | Enrichment | PSEN2 | 1.98 |
| 115 | Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy | Enrichment | RYR1 | 1.98 |
| 116 | Timothy syndrome type 1 | Enrichment | CACNA1C | 1.98 |
| 117 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.98 |
| 118 | Cacna1c-related disorders | Enrichment | CACNA1C | 1.98 |
| 119 | Benign paroxysmal torticollis of infancy | Enrichment | CACNA1A | 1.98 |
| 120 | Benign samaritan congenital myopathy | Enrichment | RYR1 | 1.98 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | RYR1, RYR2 | 1.93 |
| 122 | Alzheimer disease, familial, 1 | Enrichment | APP, PSEN1 | 1.87 |
| 123 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CACNA1I, CACNG2, CDH15 | 1.81 |
| 124 | Congenital myopathy | Enrichment | CACNA1S, RYR1 | 1.78 |
| 125 | Centronuclear myopathy | Enrichment | CACNA1S, RYR1 | 1.70 |
| 126 | Hepatoblastoma | Enrichment | APC, CTNNB1 | 1.70 |
| 127 | Undetermined early-onset epileptic encephalopathy | Enrichment | CACNA1A, CACNA1B, CACNA2D1 | 1.68 |
| 128 | Cerebral amyloid angiopathy, cst3-related | Enrichment | APP | 1.68 |
| 129 | Blepharocheilodontic syndrome 1 | Enrichment | CDH1 | 1.68 |
| 130 | Malignant hyperthermia 1 | Enrichment | RYR1 | 1.68 |
| 131 | Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | Enrichment | RYR2 | 1.68 |
| 132 | Tooth agenesis, selective, 4 | Enrichment | WNT10A | 1.68 |
| 133 | Schopf-schulz-passarge syndrome | Enrichment | WNT10A | 1.68 |
| 134 | Ulna and fibula, absence of, with severe limb deficiency | Enrichment | WNT7A | 1.68 |
| 135 | Bladder exstrophy and epispadias complex | Enrichment | WNT3 | 1.68 |
| 136 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.68 |
| 137 | Timothy syndrome | Enrichment | CACNA1C | 1.68 |
| 138 | Hypotrichosis, congenital, with juvenile macular dystrophy | Enrichment | CDH3 | 1.68 |
| 139 | Alzheimer disease 3 | Enrichment | PSEN1 | 1.68 |
| 140 | Night blindness, congenital stationary, type 2a | Enrichment | CACNA1F | 1.68 |
| 141 | Odontoonychodermal dysplasia | Enrichment | WNT10A | 1.68 |
| 142 | Tetraamelia syndrome 1 | Enrichment | WNT3 | 1.68 |
| 143 | Alternating hemiplegia of childhood 1 | Enrichment | CACNA1A | 1.68 |
| 144 | Pick disease of brain | Enrichment | PSEN1 | 1.68 |
| 145 | Osteogenesis imperfecta, type xv | Enrichment | WNT1 | 1.68 |
| 146 | Adams-oliver syndrome 5 | Enrichment | NOTCH1 | 1.68 |
| 147 | Robinow syndrome, autosomal dominant 3 | Enrichment | FZD2 | 1.68 |
| 148 | Fibular aplasia or hypoplasia, femoral bowing, and poly-, syn-, and oligodactyly | Enrichment | WNT7A | 1.68 |
| 149 | Adams-oliver syndrome 3 | Enrichment | RBPJ | 1.68 |
| 150 | Proteasome-associated autoinflammatory syndrome 5 | Enrichment | PSMB10 | 1.68 |
| 151 | Long qt syndrome 8 | Enrichment | CACNA1C | 1.68 |
| 152 | Immunodeficiency 121 with autoinflammation | Enrichment | PSMB10 | 1.68 |
| 153 | Birk-aharoni syndrome | Enrichment | PSMC1 | 1.68 |
| 154 | Infantile myofibromatosis | Enrichment | NOTCH3 | 1.68 |
| 155 | Intravascular large b-cell lymphoma | Enrichment | BCL2 | 1.68 |
| 156 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.68 |
| 157 | Ventricular tachycardia, catecholaminergic polymorphic, 2 | Enrichment | RYR2 | 1.68 |
| 158 | Lipodystrophy, familial partial, type 1 | Enrichment | NOTCH3 | 1.68 |
| 159 | King-denborough syndrome | Enrichment | RYR1 | 1.68 |
| 160 | Depressive disorder | Enrichment | NOTCH3 | 1.68 |
| 161 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 1.68 |
| 162 | Periampullary adenoma | Enrichment | APC | 1.68 |
| 163 | Gastric adenocarcinoma and proximal polyposis of the stomach | Enrichment | APC | 1.68 |
| 164 | Congenital disorder of glycosylation, type iw, autosomal dominant | Enrichment | CACNA1D | 1.68 |
| 165 | Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements | Enrichment | CACNA1B | 1.68 |
| 166 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.68 |
| 167 | Exercise-induced malignant hyperthermia | Enrichment | RYR1 | 1.68 |
| 168 | Teratoma | Enrichment | CTNNB1 | 1.68 |
| 169 | Bladder exstrophy-epispadias-cloacal exstrophy complex | Enrichment | WNT3 | 1.68 |
| 170 | Progressive bulbar palsy | Enrichment | CACNA1A | 1.68 |
| 171 | Submucosal cleft palate | Enrichment | UBB | 1.68 |
| 172 | Cleft hard palate | Enrichment | UBB | 1.68 |
| 173 | Tooth agenesis | Enrichment | WNT10A, WNT10B | 1.66 |
| 174 | Congenital stationary night blindness | Enrichment | CACNA1F, CACNA2D4 | 1.62 |
| 175 | Van der woude syndrome 1 | Enrichment | CACNA1E | 1.51 |
| 176 | Thrombocythemia 1 | Enrichment | CALR | 1.51 |
| 177 | Uvula, bifid | Enrichment | UBB | 1.51 |
| 178 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | WNT4 | 1.51 |
| 179 | Microphthalmia, syndromic 9 | Enrichment | WNT7B | 1.51 |
| 180 | Tooth agenesis, selective, 2 | Enrichment | WNT10A | 1.51 |
| 181 | Cleft soft palate | Enrichment | UBB | 1.51 |
| 182 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.51 |
| 183 | Cenani-lenz syndactyly syndrome | Enrichment | APC | 1.51 |
| 184 | Lynch syndrome 5 | Enrichment | RYR1 | 1.51 |
| 185 | Anus, imperforate | Enrichment | CTNNB1 | 1.51 |
| 186 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.51 |
| 187 | Bronchopulmonary dysplasia | Enrichment | RYR1 | 1.51 |
| 188 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL2 | 1.51 |
| 189 | Nail disease | Enrichment | FZD6 | 1.51 |
| 190 | Migraine without aura | Enrichment | NOTCH3 | 1.51 |
| 191 | Butterfly-shaped pigment dystrophy | Enrichment | CTNNA1 | 1.51 |
| 192 | Tetraamelia syndrome | Enrichment | WNT3 | 1.51 |
| 193 | Colon adenocarcinoma | Enrichment | APC | 1.51 |
| 194 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.51 |
| 195 | Thyrotoxic periodic paralysis | Enrichment | CACNA1S | 1.51 |
| 196 | Thyroid hemiagenesis | Enrichment | PSMD3 | 1.51 |
| 197 | Hereditary episodic ataxia | Enrichment | CACNA1A | 1.51 |
| 198 | Apc-associated polyposis conditions | Enrichment | APC | 1.51 |
| 199 | Migraine, familial hemiplegic, 1 | Enrichment | CACNA1A | 1.38 |
| 200 | Congenital myopathy 1a, autosomal dominant, with malignant hyperthermia | Enrichment | RYR1 | 1.38 |
| 201 | Ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive | Enrichment | WNT10A | 1.38 |
| 202 | Spinocerebellar ataxia 6 | Enrichment | CACNA1A | 1.38 |
| 203 | Myopathy, centronuclear, 2 | Enrichment | RYR1 | 1.38 |
| 204 | Sacral defect with anterior meningocele | Enrichment | RYR1 | 1.38 |
| 205 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | CTNNA1 | 1.38 |
| 206 | Autoimmune lymphoproliferative syndrome | Enrichment | CASP10 | 1.38 |
| 207 | Amyotrophy, monomelic | Enrichment | RYR3 | 1.38 |
| 208 | Budd-chiari syndrome | Enrichment | CALR | 1.38 |
| 209 | Aland island eye disease | Enrichment | CACNA1F | 1.38 |
| 210 | Developmental and epileptic encephalopathy 2 | Enrichment | CACNA1A | 1.38 |
| 211 | Pilomatrixoma | Enrichment | CTNNB1 | 1.38 |
| 212 | Developmental and epileptic encephalopathy 42 | Enrichment | CACNA1A | 1.38 |
| 213 | Alazami syndrome | Enrichment | CTNNB1 | 1.38 |
| 214 | Intellectual developmental disorder, autosomal dominant 26 | Enrichment | RYR1 | 1.38 |
| 215 | Cerebellar atrophy with seizures and variable developmental delay | Enrichment | CACNA2D2 | 1.38 |
| 216 | Developmental and epileptic encephalopathy 52 | Enrichment | CACNA1A | 1.38 |
| 217 | Dowling-degos disease | Enrichment | PSENEN | 1.38 |
| 218 | Ectodermal dysplasia | Enrichment | WNT10A | 1.38 |
| 219 | Retinopathy of prematurity | Enrichment | FZD4 | 1.38 |
| 220 | Cerebrovascular disease | Enrichment | NOTCH3 | 1.38 |
| 221 | Congenital myopathy 1a | Enrichment | RYR1 | 1.38 |
| 222 | Episodic ataxia | Enrichment | CACNA1A | 1.38 |
| 223 | Eyelid coloboma | Enrichment | FZD5 | 1.38 |
| 224 | Familial or sporadic hemiplegic migraine | Enrichment | CACNA1A | 1.38 |
| 225 | Vacterl association | Enrichment | CDH13 | 1.38 |
| 226 | Lens coloboma | Enrichment | FZD5 | 1.38 |
| 227 | Paroxysmal familial ventricular fibrillation | Enrichment | RYR2 | 1.38 |
| 228 | Episodic ataxia, type 2 | Enrichment | CACNA1A | 1.29 |
| 229 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | Enrichment | NOTCH3 | 1.29 |
| 230 | Congenital myopathy 1b, autosomal recessive | Enrichment | RYR1 | 1.29 |
| 231 | Vater/vacterl association | Enrichment | CDH13 | 1.29 |
| 232 | Norrie disease | Enrichment | FZD4 | 1.29 |
| 233 | Familial adenomatous polyposis 1 | Enrichment | APC | 1.29 |
| 234 | Follicular lymphoma | Enrichment | BCL2 | 1.29 |
| 235 | Amblyopia | Enrichment | CACNA1F | 1.29 |
| 236 | Cardiac arrest | Enrichment | CACNA2D1 | 1.29 |
| 237 | Persistent hyperplastic primary vitreous | Enrichment | FZD4 | 1.29 |
| 238 | Vascular dementia | Enrichment | NOTCH3 | 1.29 |
| 239 | Autosomal recessive hypohidrotic ectodermal dysplasia syndrome | Enrichment | WNT10A | 1.29 |
| 240 | Dementia | Enrichment | PSEN1 | 1.29 |
| 241 | Congenital short qt syndrome | Enrichment | CACNA2D1 | 1.29 |
| 242 | Coloboma of choroid and retina | Enrichment | FZD5 | 1.29 |
| 243 | Eye disease | Enrichment | CACNA1F, CACNA2D4 | 1.29 |
| 244 | Developmental and epileptic encephalopathy | Enrichment | CACNA1E, CACNA2D2 | 1.26 |
| 245 | Developmental dysplasia of the hip 1 | Enrichment | PSMC3 | 1.21 |
| 246 | Coloboma of optic nerve | Enrichment | FZD5 | 1.21 |
| 247 | Hypokalemic periodic paralysis, type 1 | Enrichment | CACNA1S | 1.21 |
| 248 | Myopathy, centronuclear, 1 | Enrichment | RYR1 | 1.21 |
| 249 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.21 |
| 250 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | PSEN1 | 1.21 |
| 251 | Renal dysplasia, cystic | Enrichment | WNT9B | 1.21 |
| 252 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | RYR2 | 1.21 |
| 253 | Renal hypoplasia | Enrichment | WNT9B | 1.21 |
| 254 | Diarrhea | Enrichment | WNT2B | 1.21 |
| 255 | Patent ductus arteriosus | Enrichment | PSMC3 | 1.21 |
| 256 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.21 |
| 257 | Multicystic kidney dysplasia | Enrichment | FZD3 | 1.21 |
| 258 | Childhood absence epilepsy | Enrichment | CACNA1H | 1.21 |
| 259 | Cleft lip with or without cleft palate | Enrichment | CDH1 | 1.21 |
| 260 | Multicystic dysplastic kidney | Enrichment | FZD3 | 1.21 |
| 261 | Cerebral palsy | Enrichment | CACNA1A, CACNA1C | 1.20 |
| 262 | Myelofibrosis | Enrichment | CALR | 1.15 |
| 263 | Brugada syndrome 1 | Enrichment | CACNA2D1 | 1.15 |
| 264 | Coats disease | Enrichment | FZD4 | 1.15 |
| 265 | Semantic dementia | Enrichment | PSEN1 | 1.15 |
| 266 | Alzheimer's disease 1 | Enrichment | APP | 1.15 |
| 267 | Essential thrombocythemia | Enrichment | CALR | 1.15 |
| 268 | Gallbladder cancer | Enrichment | CTNNB1 | 1.15 |
| 269 | Distal arthrogryposis | Enrichment | FZD3, RYR1 | 1.15 |
| 270 | Hereditary breast carcinoma | Enrichment | APC, CDH1 | 1.11 |
| 271 | Multiple pterygium syndrome, lethal type | Enrichment | RYR1 | 1.09 |
| 272 | Renal hypodysplasia/aplasia 1 | Enrichment | WNT9B | 1.09 |
| 273 | Lymphoma, non-hodgkin, familial | Enrichment | CASP10 | 1.09 |
| 274 | Lennox-gastaut syndrome | Enrichment | CACNA1A | 1.09 |
| 275 | Alternating hemiplegia of childhood | Enrichment | CACNA1A | 1.09 |
| 276 | Congenital muscular dystrophy | Enrichment | RYR1 | 1.09 |
| 277 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | RYR2 | 1.09 |
| 278 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | RYR2 | 1.09 |
| 279 | Hypoplastic left heart syndrome | Enrichment | NOTCH1 | 1.09 |
| 280 | Difference of sex development | Enrichment | CACNA1A | 1.09 |
| 281 | Ovarian cancer | Enrichment | APC, CDH1, CTNNB1 | 1.05 |
| 282 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | CACNA1C | 1.04 |
| 283 | Progressive non-fluent aphasia | Enrichment | PSEN1 | 1.04 |
| 284 | Primary hyperaldosteronism | Enrichment | CACNA1H | 1.04 |
| 285 | Colonic benign neoplasm | Enrichment | APC | 1.04 |
| 286 | Hypotrichosis simplex | Enrichment | CDH3 | 1.04 |
| 287 | Behavioral variant of frontotemporal dementia | Enrichment | PSEN1 | 1.04 |
| 288 | Renal agenesis, bilateral | Enrichment | WNT9B | 1.04 |
| 289 | Congenital nervous system abnormality | Enrichment | CACNA1A, CTNNB1, PSEN1 | 1.00 |
| 290 | Nervous system disease | Enrichment | CACNA1A, CTNNB1, PSEN1 | 1.00 |
| 291 | Cat eye syndrome | Enrichment | FZD5 | 1.00 |
| 292 | Omenn syndrome | Enrichment | PSMB10 | 1.00 |
| 293 | Stroke, ischemic | Enrichment | NOTCH3 | 1.00 |
| 294 | Polymicrogyria | Enrichment | PSMC3 | 1.00 |
| 295 | Spastic ataxia | Enrichment | CACNA1G, CACNB4 | 0.97 |
| 296 | Familial isolated dilated cardiomyopathy | Enrichment | PSEN1, PSEN2 | 0.97 |
| 297 | Epilepsy, myoclonic juvenile | Enrichment | CACNB4 | 0.96 |
| 298 | Frontotemporal dementia 1 | Enrichment | PSEN1 | 0.96 |
| 299 | Epilepsy, idiopathic generalized | Enrichment | CACNA1H | 0.96 |
| 300 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | RYR2 | 0.93 |
| 301 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | RYR2 | 0.93 |
| 302 | Primary ovarian insufficiency | Enrichment | NOTCH2, RYR3 | 0.90 |
| 303 | Aortic valve disease 1 | Enrichment | NOTCH1 | 0.89 |
| 304 | Microphthalmia/coloboma 12 | Enrichment | FZD5 | 0.89 |
| 305 | Osteogenesis imperfecta, type iv | Enrichment | WNT1 | 0.89 |
| 306 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | RYR1 | 0.89 |
| 307 | Clubfoot | Enrichment | RYR1 | 0.89 |
| 308 | Chronic kidney disease | Enrichment | WNT9B | 0.89 |
| 309 | Osteoporosis | Enrichment | WNT1 | 0.86 |
| 310 | Aortic aneurysm, familial thoracic 1 | Enrichment | NOTCH1 | 0.86 |
| 311 | Cleft lip/palate | Enrichment | CDH1 | 0.86 |
| 312 | Coloboma of macula | Enrichment | FZD5 | 0.84 |
| 313 | Congenital myopathy 4a, autosomal dominant | Enrichment | RYR1 | 0.84 |
| 314 | Corpus callosum, agenesis of | Enrichment | CDH2 | 0.84 |
| 315 | Osteogenesis imperfecta, type iii | Enrichment | WNT1 | 0.84 |
| 316 | Hydrocephalus | Enrichment | FZD3 | 0.84 |
| 317 | Myopia | Enrichment | CACNA1F | 0.84 |
| 318 | Isolated corpus callosum agenesis | Enrichment | CDH2 | 0.84 |
| 319 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | CDH2 | 0.84 |
| 320 | Cone-rod dystrophy 2 | Enrichment | CACNA1F, CACNA2D4 | 0.80 |
| 321 | Inherited cancer-predisposing syndrome | Enrichment | APC, CDH1, CTNNA1 | 0.79 |
| 322 | Polycystic liver disease | Enrichment | CTNNB1 | 0.79 |
| 323 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.79 |
| 324 | Beckwith-wiedemann syndrome | Enrichment | RYR1 | 0.76 |
| 325 | Neuromuscular disease | Enrichment | RYR1 | 0.76 |
| 326 | Patent foramen ovale | Enrichment | PSMC3 | 0.76 |
| 327 | Arteriovenous malformations of the brain | Enrichment | CDH2 | 0.74 |
| 328 | Hereditary retinal dystrophy | Enrichment | CACNA1F, CACNA2D4, CDH3, CTNNA1, FZD4 | 0.73 |
| 329 | Fundus dystrophy | Enrichment | CACNA1F, CACNA2D4, CDH3, CTNNA1, FZD4 | 0.73 |
| 330 | Macs syndrome | Enrichment | WNT7B | 0.72 |
| 331 | Craniosynostosis | Enrichment | CTNNA1 | 0.72 |
| 332 | Endometrial cancer | Enrichment | CDH1 | 0.70 |
| 333 | Myocardial infarction | Enrichment | PSMA6 | 0.68 |
| 334 | Microphthalmia | Enrichment | WNT7B | 0.68 |
| 335 | Skin disease | Enrichment | NCSTN | 0.68 |
| 336 | Brittle bone disorder | Enrichment | WNT1 | 0.67 |
| 337 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | CACNA1C | 0.65 |
| 338 | Cone dystrophy | Enrichment | CACNA2D4 | 0.65 |
| 339 | Autoinflammatory disease | Enrichment | PSMB8 | 0.65 |
| 340 | Scoliosis | Enrichment | RYR1 | 0.65 |
| 341 | Tetralogy of fallot | Enrichment | NOTCH1 | 0.62 |
| 342 | Hydrops fetalis, nonimmune | Enrichment | FZD6 | 0.62 |
| 343 | Strabismus | Enrichment | CACNA1A | 0.61 |
| 344 | Bladder cancer | Enrichment | CTNNB1 | 0.58 |
| 345 | Prostate cancer | Enrichment | CDH1 | 0.58 |
| 346 | Severe covid-19 | Enrichment | CASP10 | 0.58 |
| 347 | Long qt syndrome 1 | Enrichment | CACNA1C | 0.57 |
| 348 | Non-immune hydrops fetalis | Enrichment | FZD6 | 0.55 |
| 349 | Lung cancer | Enrichment | CASP8 | 0.54 |
| 350 | Connective tissue disease | Enrichment | NOTCH1 | 0.54 |
| 351 | Left ventricular noncompaction | Enrichment | RYR2 | 0.51 |
| 352 | Fetal akinesia deformation sequence 1 | Enrichment | RYR1 | 0.49 |
| 353 | Myopathy | Enrichment | RYR1 | 0.46 |
| 354 | Type 2 diabetes mellitus | Enrichment | RBPJ | 0.45 |
| 355 | Microcephaly | Enrichment | CTNNB1, PSMC3 | 0.43 |
| 356 | Optic atrophy plus syndrome | Enrichment | CACNA1F | 0.43 |
| 357 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | NOTCH1 | 0.43 |
| 358 | Complex neurodevelopmental disorder | Enrichment | CACNA1C, DOCK3 | 0.43 |
| 359 | Retinitis pigmentosa | Enrichment | CACNA1F, CACNA2D4, CDH3 | 0.42 |
| 360 | Hereditary breast ovarian cancer syndrome | Enrichment | CTNNA1 | 0.36 |
| 361 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PSEN1 | 0.34 |